Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
This study is currently recruiting participants.
Verified March 2013 by Genfit
Sponsor:
Genfit
Collaborators:
NATURALPHA
PREMIER RESEARCH GROUP
Information provided by (Responsible Party):
Genfit
ClinicalTrials.gov Identifier:
NCT01694849
First received: September 24, 2012
Last updated: March 20, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2015 |
| Estimated Primary Completion Date: | October 2014 (Final data collection date for primary outcome measure) |